Obesity may be erythropoietin dose-saving in hemodialysis patients
Background : In dialysis patients, the obesity-survival paradox still requires an explanation. Anemia and high doses of erythropoiesis-stimulating agents (ESAs) are associated with worse outcomes in the hemodialysis (HD) population. In the present study, we explored the relation between obesity and...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2018-06-01
|
Series: | Kidney Research and Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.23876/j.krcp.2018.37.2.148 |